Abbott Laboratories (NYSE:ABT), in the last week of February created a record of sorts when its board of directors, under the guidance of Mr. Miles D. White, the Chairman of the Board and its Chief Executive Officer declared quarterly dividends to be paid out to its shareholders for the 361st consecutive quarter. The dividend payout of $0.22 per share is expected to be paid out on 15th May to all share holders on record as of 15th April. The stock is expected to go ex dividend on 12th April. This marks the 361st consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2014, to shareholders of record at the close of business on April 15, 2014. Abbott Laboratories (NYSE:ABT) stock opened at $39.92 in last session, and closed at $39.73, while the day range of ABT stock is $39.73-$40.23.The stock showed a negative weekly performance of -0.15%.
Opko Health (NYSE:OPK) released its earnings data on Monday. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.01, Stock Ratings Network.com reports. The company had revenue of $20.70 million for the quarter, compared to the consensus estimate of $23.64 million. The company’s quarterly revenue was up 27.8% on a year-over-year basis. Opko Health Inc. (NYSE:OPK) stock opened at $9.45, in last session and closed at $8.99, by loosed -4.36%. The 52 week range was $6.14-$12.95. Company’s market capitalization is $3.71 billion.
Hologic, Inc. (Nasdaq: HOLX) announced that the American Medical Association (AMA) CPT Editorial Panel posted its Summary of Panel Actions from the February, 2014 Panel Meeting. Hologic, Inc. (NASDAQ:HOLX) stock gained 1.71% and finished the last session at $21.98. The EPS of the stock remained -4.36.Company’s market capitalization is $6.03 billion.
The FDA sets October 16, 2014 as the target review date for Navidea Pharmaceuticals (NAVB) supplemental New Drug Application ((sNDA)) for the label expansion of Lymphoseek. Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) stock opened the session at $1.96, and closed the session at 2.00. The 52 week range of the NAVB stock remained $1.11-$3.59 and the day range was $1.93-$2.08.